AMGEN (AMGN) P/B (1999 - 2026)
AMGEN (AMGN) P/B from Nov 1, 1999 to Jul 21, 2026. The TTM AMGEN (AMGN) P/B is 21.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of AMGEN (AMGN)
| Year | P/B | Change |
|---|---|---|
| 2026 | 21.51 | +5.59% |
| 2025 | 20.37 | -14.46% |
| 2024 | 23.81 | +18.28% |
| 2023 | 20.13 | -47.52% |
| 2022 | 38.36 | +104.61% |
| 2021 | 18.75 | +32.66% |
| 2020 | 14.13 | -4.12% |
| 2019 | 14.74 | +50.32% |
| 2018 | 9.81 | +150.10% |
| 2017 | 3.92 | +10.79% |
| 2016 | 3.54 | -18.81% |
| 2015 | 4.36 | -7.24% |
| 2014 | 4.70 | +20.61% |
| 2013 | 3.90 | +13.90% |
| 2012 | 3.42 | +42.74% |
| 2011 | 2.40 | +12.14% |
| 2010 | 2.14 | -13.94% |
| 2009 | 2.48 | -14.23% |
| 2008 | 2.90 | +3.32% |
| 2007 | 2.80 | -30.15% |
| 2006 | 4.01 | -13.38% |
| 2005 | 4.63 | +22.93% |
| 2004 | 3.77 | +3.82% |
| 2003 | 3.63 | +27.82% |
| 2002 | 2.84 | -14.35% |
| 2001 | 3.31 | -11.73% |
| 2000 | 3.75 | +6.46% |
| 1999 | 3.53 | N/A |
Comparison AMGEN (AMGN) P/B with competitors
AMGEN (AMGN) P/B is 21.51.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -96.82% |
| GRFS | Grifols SA | 0.79 | -96.33% |
| SNY | Sanofi | 1.27 | -94.10% |
| BIIB | Biogen Inc | 1.52 | -92.94% |
| PFE | Pfizer Inc | 1.55 | -92.80% |
| OGN | Organon & Company | 3.93 | -81.75% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -80.98% |
| GSK | GSK Plc | 4.37 | -79.67% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -71.92% |
| AZN | Astrazeneca plc | 6.20 | -71.17% |
| MRK | Merck & Co Inc | 6.68 | -68.94% |
| GILD | Gilead Sciences Inc | 6.94 | -67.73% |
| NVO | Novo Nordisk | 7.07 | -67.13% |
| NVS | Novartis AG | 7.60 | -64.66% |
| JNJ | Johnson & Johnson | 7.64 | -64.48% |
| NSRX | Nasus Pharma Ltd | 12.90 | -40.02% |
| MDCX | MDCorp | 15.34 | -28.68% |
| SCLX | Scilex Holding Company | 28.85 | +34.14% |
| LLY | Lilly(Eli) & Company | 32.94 | +53.15% |
| ABBV | Abbvie Inc | 50.46 | +134.61% |